IL2 and autoimmune disease: Increased concentrations of serum soluble IL-2 have been found in patients with diverse diseases, including lymphoma, leukemia, sarcoidosis, tuberculosis, viral infection, autoimmune diseases, and organ allograft rejection [20–22].